Search

Author/Creator Logan, Theodore F

1. A multi-center study of high dose Aldesleukin (Proleukin® (HD IL-2) + Vemurafenib Zelboraf® ) therapy in patients with BRAFV600 mutation positive metastatic melanoma (proclivity 01). (6th November 2014)

Authors:
Clark, Joseph; Flaherty, Lawrence; Ernstoff, Marc; Koon, Henry; Milhem, Mohammed; Militello, Gerald; Agarwala, Sanjiv; Curti, Brendan; Cranmer, Lee; Lao, Christopher D; Logan, Theodore F; Lutzky, Jose; Rudrapatna, Venkatesh; Daniels, Gregory; Taback, Bret; Aung, Sandra; Lowder, James; Lawson, David
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial. Issue 3 (March 2016)

Authors:
Armstrong, Andrew J; Halabi, Susan; Eisen, Tim; Broderick, Samuel; Stadler, Walter M; Jones, Robert J; Garcia, Jorge A; Vaishampayan, Ulka N; Picus, Joel; Hawkins, Robert E; Hainsworth, John D; Kollmannsberger, Christian K; Logan, Theodore F; Puzanov, Igor; Pickering, Lisa M; Ryan, Christopher W;...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 3(2016:Mar.)
Page Start:
378
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2. (4th February 2021)

Authors:
Clark, Joseph I; Curti, Brendan; Davis, Elizabeth J; Kaufman, Howard; Amin, Asim; Alva, Ajjai; Logan, Theodore F; Hauke, Ralph; Miletello, Gerald P; Vaishampayan, Ulka; Johnson, Douglas B; White, Richard L; Wiernik, Peter H; Dutcher, Janice P
Journal:
Journal of investigative medicine
Issue:
Volume 69:Number 4(2021)
Page Start:
888
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2. (4th February 2021)

Authors:
Clark, Joseph I; Curti, Brendan; Davis, Elizabeth J; Kaufman, Howard; Amin, Asim; Alva, Ajjai; Logan, Theodore F; Hauke, Ralph; Miletello, Gerald P; Vaishampayan, Ulka; Johnson, Douglas B; White, Richard L; Wiernik, Peter H; Dutcher, Janice P
Journal:
Journal of investigative medicine
Issue:
Volume 69:Number 4(2021)
Page Start:
888
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Long-Term Progression-Free Survival of Patients with Metastatic Melanoma or Renal Cell Carcinoma following High-Dose Interleukin-2. (April 2021)

Authors:
Clark, Joseph I; Curti, Brendan; Davis, Elizabeth J; Kaufman, Howard; Amin, Asim; Alva, Ajjai; Logan, Theodore F; Hauke, Ralph; Miletello, Gerald P; Vaishampayan, Ulka; Johnson, Douglas B; White, Richard L; Wiernik, Peter H; Dutcher, Janice P
Journal:
Journal of investigative medicine
Issue:
Volume 69:Number 4(2021)
Page Start:
888
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial. Issue 7 (July 2016)

Authors:
Weber, Jeffrey S; Gibney, Geoff; Sullivan, Ryan J; Sosman, Jeffrey A; Slingluff, Craig L; Lawrence, Donald P; Logan, Theodore F; Schuchter, Lynn M; Nair, Suresh; Fecher, Leslie; Buchbinder, Elizabeth I; Berghorn, Elmer; Ruisi, Mary; Kong, George; Jiang, Joel; Horak, Christine; Hodi, F Stephen
Journal:
Lancet oncology
Issue:
Volume 17:Issue 7(2016:Jul.)
Page Start:
943
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results. Issue 1 (21st April 2015)

Authors:
Amin, Asim; Dudek, Arkadiusz Z; Logan, Theodore F; Lance, Raymond S; Holzbeierlein, Jeffrey M; Knox, Jennifer J; Master, Viraj A; Pal, Sumanta K; Miller, Wilson H; Karsh, Lawrence I; Tcherepanova, Irina Y; DeBenedette, Mark A; Williams, W Lee; Plessinger, Douglas C; Nicolette, Charles A; Figlin, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 1(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗